Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey
Key result
Among 52 surveyed European centres, 86% reported using leadless pacemakers, primarily for permanent atrial fibrillation (83%) or difficult vascular access (91%), though use is limited by cost (91%).
Why the study?
What is the current use, indications, and perception of leadless pacemakers across European centres?
Population
52 centres participating in the European Heart Rhythm Association (EHRA) Electrophysiology Research Network
Design
Cross-sectional
Authors
Discussion
Loading...
Member takes
Implication
Cost limits leadless pacemaker adoption despite selective use; leaves open need for cost-effectiveness data before broader practice change.
Study Design
Type
Cross-Sectional (n=52)
Multicenter
Yes
Structured PICO
What is the current use, indications, and perception of leadless pacemakers across European centres?
P
Population
52 European centres participating in the EHRA Electrophysiology Research Network surveyed on their use of leadless pacemakers.
E
Exposure
Use of leadless pacemakers (LLPM)
O
Outcome
Overview of current use, standards of care, policies, indications, and techniques of implantation of LLPM
Despite cost and reimbursement limitations, leadless pacemakers are widely adopted in European centres for specific indications, with most implanters perceiving the procedure as safe and easy.
Cite This Study
Bovéda et al. (2018) conducted a cross-sectional in Leadless pacemaker implantation (n=52). Leadless pacemakers was evaluated on Current use, indications, and techniques of implantation of leadless pacemakers. Among 52 surveyed European centres, 86% reported using leadless pacemakers, primarily for permanent atrial fibrillation (83%) or difficult vascular access (91%), though use is limited by cost (91%).